NewEdge Wealth’s Dr. Reddy's Laboratories RDY Stock Holding History

NewEdge Wealth’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18,747	Closed	-$247K	–	1021
2025 Q1	$247K	Buy	18,747 +2,825	+18%	+$39K	﹤0.01%	818
2024 Q4	$251K	Sell	15,922 -4,813	-23%	-$72.3K	﹤0.01%	812
2024 Q3	$329K	Buy	+20,735	New	+$334K	0.01%	706

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NewEdge Wealth's RDY Position: Q2 2025 in Review

NewEdge Wealth sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 18,747 shares — an estimated $247K sold.

NewEdge Wealth first reported a position in RDY in Q3 2024 and held it in 3 quarters. The position peaked at $329K in Q3 2024. 242 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

NewEdge Wealth reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
NewEdge Wealth sold 18,747 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $247K.
NewEdge Wealth first reported a position in Dr. Reddy's Laboratories in Q3 2024 and held it in 3 quarters.
NewEdge Wealth's Dr. Reddy's Laboratories position peaked at $329K in Q3 2024.
242 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on NewEdge Wealth's 13F filing for Q2 2025, filed 11 Aug 2025.